Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: QLS5212 for Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial update for QLS5212 in participants with advanced solid tumors, currently not yet recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 trial evaluating DCSZ11 in combination with standard therapy for advanced or metastatic solid tumors is currently recruiting. Th…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors [Phase 1, Phase 2]
DT-7012 is being studied as a single agent and in combination with an immune checkpoint inhibitor in a Phase 1/2 trial for advanced solid tu…
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Novel Molecular Approach to Blood DNA Screening for Cancer: Specificity Assessment (The NOMAD Study)
The NOMAD study at Mayo Clinic is evaluating a novel blood DNA screening approach for cancer, currently recruiting to assess test specificit…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Dasatinib, Temsirolimus, and Cyclophosphamide in Treating Patients With Advanced, Recurrent, or Refractory Solid Tumors [Phase 1]
A Phase 1 trial evaluating the combination of dasatinib, temsirolimus, and cyclophosphamide for advanced malignant solid tumors and recurren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors [Phase 1]
Phase 1 trial of ALTA2618 for AKT1 E17K-mutant solid tumors is currently recruiting, with breast cancer and endometrial cancer among the ind…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors [Phase 1]
Phase 1 trial evaluating NEROFE in combination with doxorubicin for KRAS-mutant ST2-positive solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Combining Epigenetic And Immune Therapy to Beat Cancer. [Phase 2]
A Phase 2 trial from Institut Bergonié evaluating a combination of epigenetic therapy and immunotherapy in several advanced cancers has comp…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors [Phase 1]
A Phase 1 study of CF33-hNIS (VAXINIA), an oncolytic virus, given alone or with pembrolizumab, in adults with metastatic or advanced solid t…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) [Phase 1]
The Phase 1 OASIS study evaluating onCARlytics CF33-CD19 CAR-T in combination with blinatumomab in adults with advanced or metastatic solid …
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton Therapy [NA]
A clinical trial from Washington University tests palliative GRID radiotherapy using intensity-modulated proton therapy for unresectable sol…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 study is evaluating PYX-201 in combination with pembrolizumab for advanced solid tumors; the trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: QLS5132 Combination Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
This update describes a Phase 1/2 study of QLS5132 combination therapy in multiple cancers, including gastric cancer, non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: TNFα and IL-2 Coding Oncolytic Adenovirus TILT-123 Monotherapy [Phase 1]
Phase 1 trial of TNFα and IL-2 coding oncolytic adenovirus TILT-123 as monotherapy for solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-05Clinical Trial Update: Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer [Phase 2]
Phase 2 trial evaluating psilocybin-assisted existential therapy (PEARL) for patients with advanced cancers; the study is currently active b…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Advanced or Recurrent Solid Tumors Treated With SHetA2 [Phase 1]
A Phase 1 clinical trial evaluating SHetA2 in adults with advanced or recurrent solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Patient Reported Symptom Control With THC or CBD Use
This clinical trial update discusses patient-reported symptom control with tetrahydrocannabinol (THC) or cannabidiol (CBD) in cancer patient…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas [Phase 1]
Phase 1, open-label, multicenter dose-escalation study of IBI363 (PD1-IL2m) in adults with advanced solid tumors or lymphomas; trial status …
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Clinical trial update for SB-4826 in adults with locally advanced or metastatic solid tumors or non-Hodgkin lymphoma, currently recruiting i…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma [Phase 1]
A Phase 1 clinical trial evaluating TR-002 for advanced unresectable or metastatic solid tumors and unresectable or metastatic pancreatic ad…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors [Phase 1]
A Phase 1 clinical trial update for a CD70-targeted CAR T therapy (CD70.CAR) in CD70-positive lymphoma, multiple myeloma, solid tumors, sarc…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene Abnormalities [Phase 1, Phase 2]
A Phase 1/2 clinical trial of TAS0953/HM06, a RET inhibitor, in adults with RET-altered advanced solid tumors including non-small cell lung …
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment [NA]
This clinical trial evaluates a virtually delivered diet intervention (LASO-3) intended to improve chemotherapy-induced peripheral neuropath…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers [Phase 1]
Nuvectis Pharma reports a Phase 1 clinical trial of NXP-900 in subjects with advanced cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: A Study to Evaluate Safety, PK and Efficacy of GH55 in Combination With GH21 in Patients With Solid Tumors [Phase 1, Phase 2]
A phase 1/2 clinical trial to evaluate safety, pharmacokinetics, and efficacy of GH55 in combination with GH21 in patients with advanced sol…